Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model

By sjmartinez • April 5, 2023

Zhang P, Miyata KN, Nast CC, LaPage JA, Mahoney M, Nguyen S, Khan K, Wu Q, Adler SG, Dai T. Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model. Perit Dial Int. 2023 Mar;43(2):159-167. doi: 10.1177/08968608221116956. Epub 2022 Aug 9. PMID: 35946050.

Tags: Angiogenesis, fibrosis, Harbor UCLA, JAK inhibitor, Nephrology, peritoneal dialysis, peritoneal membrane, Publications

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation

Rhee CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV. Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation. Curr Opin[...]

Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation

Lobo AS, Vaughan L, Ainsworth AJ, Felt M, Elali I, Arriola-Montenegro J, Garovic VD, Kattah AG. Sex hormones and sexual health in chronic kidney disease[...]